Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM
Harvard Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -58.05M | -12.4M | -14.24M | -10.68M | -8.73M | -3.42M | -3.26M | -5.43M | -2.01M | -9.52M | -6.89M | -3.65M | -6.5M | -288K | -1.86M | -2.79M | -3.96M |
Depreciation & Amortization | 6.94M | 7.03M | 7.08M | 7.05M | 7.01M | 6.99M | 7.18M | 7.34M | 7.45M | 7.58M | 7.54M | 7.48M | 7.56M | 7.62M | 7.62M | 7.59M | 7.63M |
Stock-Based Compensation | 3.89M | 4.34M | 4.76M | 5.07M | 4.89M | 5M | 4.63M | 4.4M | 4.54M | 4.41M | 4.43M | 4.3M | 4.22M | 4.17M | 4.14M | 4.22M | 3.82M |
Other Working Capital | 1.73M | 886K | 2.12M | 559K | 1.17M | 2.08M | 3.18M | 2.24M | -782K | -1.7M | -6.03M | -5.32M | -1.97M | -2.04M | 744K | -378K | -537K |
Other Non-Cash Items | 6.39M | 9.78M | 11.22M | 8.45M | 4.24M | 513K | 250K | 1.46M | -4.02M | -3.62M | -3.62M | -3.62M | 333K | 280K | 1.78M | 4.35M | 7.63M |
Deferred Income Tax | 546K | 724K | 244K | 657K | 569K | 336K | -162K | -1.37M | -346K | -414K | 8K | 1.01M | -453K | -330K | -641K | -3.37M | -5.79M |
Change in Working Capital | -2.3M | -593K | 2.39M | 6.11M | 7.6M | 4.6M | 3.77M | 2.29M | -656K | 2.72M | -2.88M | -8.24M | -6.93M | -10.19M | -7.41M | -4.09M | -1.83M |
Operating Cash Flow | 3.02M | 1.44M | 4.02M | 9.22M | 13.62M | 14.03M | 12.4M | 8.69M | 4.95M | 1.15M | -1.41M | -2.72M | -1.76M | 1.26M | 3.63M | 5.89M | 7.5M |
Capital Expenditures | -2.44M | -2.64M | -3.4M | -3.15M | -2.81M | -2.31M | -1.49M | -1.53M | -1.34M | -1.59M | -1.71M | -1.75M | -1.51M | -1.34M | -1.05M | -1.14M | -1.21M |
Cash Acquisitions | n/a | n/a | -512K | -512K | -512K | n/a | 512K | 512K | 512K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.42M | 1.92M | 1.92M | 1.92M | 495K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 487K | 582K | 1.26M | 1.53M | 145K | 732K | -1.37M | -1.19M | -1.08M | -1.59M | -1.2M | -1.2M | -1.2M | -1.34M | -400K | -400K | -400K |
Investing Cash Flow | -1.8M | -1.34M | -1.94M | -1.23M | -2.31M | -1.8M | -973K | -1.01M | -831K | -1.59M | -1.71M | -1.75M | -1.51M | -1.34M | -1.3M | -1.39M | -1.46M |
Debt Repayment | 1.25M | 227K | -1.02M | -6.02M | -8.72M | -10.54M | -10.79M | -7.34M | -5.19M | -1.79M | 3.76M | 4.96M | 5.01M | -52K | 1.94M | -301K | -5.27M |
Common Stock Repurchased | 47K | n/a | 451K | 392K | 109K | n/a | -912K | -1.3M | -1.28M | -1.63M | -2.03M | -3.3M | -3.55M | -3.51M | -2.91M | -1.87M | -1.36M |
Dividend Paid | n/a | n/a | -481K | -481K | -481K | -481K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.53M | -373K | -1.4M | -1.25M | -1.11M | -956K | 660K | 724K | 650K | 577K | -515K | -2.14M | -2.08M | -2.68M | -3.5M | -1.93M | -2.07M |
Financial Cash Flow | -280K | -131K | -2.89M | -7.74M | -10.3M | -12.13M | -10.75M | -7.62M | -5.82M | -2.84M | 2.49M | 2.5M | 2.98M | -252K | 511K | -827K | -6.04M |
Net Cash Flow | 1.29M | -175K | -771K | -293K | 449K | -242K | 179K | 65K | -1.64M | -3.31M | -404K | -1.98M | -382K | -496K | 2.74M | 3.61M | -67K |
Free Cash Flow | 586K | -1.2M | 614K | 6.07M | 10.81M | 11.72M | 10.92M | 7.17M | 3.61M | -438K | -3.12M | -4.47M | -3.28M | -83K | 2.58M | 4.76M | 6.29M |